Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.0856
Schlusskurs vom Vortag:
$0.0856
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$9.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.88M
KGV:
0.00
EPS:
-0.21
Netto-Cashflow:
$-11.02M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$0.924
Know Labs Inc Stock (KNW) Company Profile
Firmenname
Know Labs Inc
Sektor
Telefon
206-903-1351
Adresse
500 UNION STREET, SEATTLE
Vergleichen Sie KNW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KNW
Know Labs Inc
|
0.00 | 9.52M | 0 | -15.88M | -11.02M | -0.21 |
|
GRMN
Garmin Ltd
|
219.78 | 42.20B | 5.96B | 1.52B | 1.26B | 7.88 |
|
KEYS
Keysight Technologies Inc
|
177.59 | 30.71B | 4.98B | 614.00M | 898.00M | 3.50 |
|
FTV
Fortive Corp
|
79.84 | 27.70B | 6.20B | 889.30M | 1.35B | 2.51 |
|
TDY
Teledyne Technologies Inc
|
510.00 | 23.77B | 5.59B | 943.80M | 929.00M | 19.78 |
|
TRMB
Trimble Inc
|
75.37 | 18.53B | 3.63B | 1.48B | 477.90M | 5.98 |
Know Labs Inc Aktie (KNW) Neueste Nachrichten
Know Labs Technology Licensing (KTL) Announces Formalized Client Engagement - BioSpace
Major IP Monetization Play: Know Labs Unveils Revolutionary RF Technology Licensing Program - StockTitan
Know Labs appeals NYSE delisting as it shifts to OTC market - Investing.com
Know Labs Fights NYSE Delisting While Advancing Revolutionary Medical Tech - StockTitan
KNOW LABS : Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K/A) - Marketscreener.com
KNOW LABS, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure (form 8-K) - Marketscreener.com
Know Labs, Inc. Announces Laboratory Comparison Tests of its UBAND™ Non-Invasive Blood Glucose Technology and Abbott Labs FreeStyle Libre - Marketscreener.com
Know Labs, Inc. Appoints Larry K. Ellingson to Medical, Scientific and Regulatory Advisory Board - Marketscreener.com
Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving -October 16, 2024 at 09:17 am EDT - Marketscreener.com
Know Labs : Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards Form 8 K - Marketscreener.com
Know Labs, Inc. Reports Third Quarter FY 2024 Results -August 14, 2024 at 04:17 pm EDT - Marketscreener.com
Know Labs, Inc. Appoints Michael Grabham as Chief Business Officer -May 30, 2018 at 09:00 am EDT - Marketscreener.com
Know Labs, Inc. Appoints Mark Tapsak as Vice President, Intellectual Property -April 16, 2019 at 09:00 am EDT - Marketscreener.com
Know Labs, Inc. Appoints Donna Ryan to Advisory Board -September 11, 2019 at 09:00 am EDT - Marketscreener.com
Know Labs, Inc. Announces CEO Changes -January 26, 2023 at 09:00 am EST - Marketscreener.com
Know Labs, Inc. Study Validates Technical Feasibility of Its Novel Sensor for Non-Invasive Glucose Monitoring - Marketscreener.com
Visualant Inc. Announces Management Changes -April 11, 2018 at 09:00 am EDT - Marketscreener.com
Know Labs : EXTENSION OF WARRANT AGREEMENT Form 8 K -December 18, 2024 at 04:25 pm EST - Marketscreener.com
Know Labs, Inc. Announces $300K Registered Direct Offering -December 16, 2024 at 11:05 am EST - Marketscreener.com
Know Labs, Inc. Furthers External Validation of Bio-RFID(TM) Technology with Study Published in Sensors Journal - Marketscreener.com
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results -November 18, 2024 at 07:05 am EST - Marketscreener.com
Know Labs, Inc. Announces Formation of Advisory Board -April 23, 2019 at 09:06 am EDT - Marketscreener.com
Know Labs : Earnings Release FY 2024 -November 14, 2024 - Marketscreener.com
Know Labs, Inc. to Present Clinical Research At the 2024 American Association of Clinical Endocrinology Annual Meeting - Marketscreener.com
Know Labs, Inc. Launches Know Labs Technology Licensing -January 21, 2025 at 05:00 am EST - Marketscreener.com
Know Labs transitions to OTC market amid delisting process By Investing.com - Investing.com Australia
Know Labs transitions to OTC market amid delisting process - Investing.com
Know Labs Responds to NYSE Commencement of Proceedings to Delist -January 30, 2025 at 09:12 am EST - Marketscreener.com
Know Labs Hit With NYSE Delisting: Inside Their Fight to Stay Afloat Despite Tech Progress - StockTitan
Know Labs stock hits 52-week low at $0.12 amid market challenges - MSN
Know Labs stock hits 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa
Know Labs Launches Know Labs Technology Licensing (KTL) - Lelezard
KNWKnow Labs, Inc. Latest Stock News & Market Updates - StockTitan
Know Labs Launches Technology Licensing Unit to Expand RFDS Beyond Medical Diagnostics - StockTitan
Know Labs stock hits 52-week low at $0.13 amid market challenges - Investing.com Canada
Astera Labs, Inc. (ALAB) Stock Moves -0.82%: What You Should Know - MSN
Know Labs (NYSEAMERICAN:KNW) Shares Up 20.7% – Here’s What Happened - Defense World
Know Labs (OTCMKTS:KNWN) Trading Down 15.2% – Here’s What Happened - Defense World
Diabetes: Most Read Stories From 2024 - Drug Topics
James Anderson, MD, Joins Know Labs as Medical Director - Marketscreener.com
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results - Marketscreener.com
Most Read Stories From 2024 - Drug Topics
Know Labs extends debt maturity to 2025 - Investing.com India
Know Labs extends key warrant expiration dates - Investing.com India
Know Labs extends debt maturity to 2025 By Investing.com - Investing.com Australia
Know Labs extends key warrant expiration dates By Investing.com - Investing.com UK
Know Labs : EXTENSION OF WARRANT AGREEMENT Form 8 K - Marketscreener.com
Know Labs : Announces $300K Registered Direct Offering Form 8 K - Marketscreener.com
Know Labs stock hits 52-week low at $0.18 amid market challenges - Investing.com Canada
Verselabs introduces verseOS: The Web3-Native Operating System Empowering Seamless Web3 Experience - GlobeNewswire Inc.
Know Labs (OTCMKTS:KNWN) Stock Price Down 5.4% – Here’s Why - Defense World
Finanzdaten der Know Labs Inc-Aktie (KNW)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.10%
0.37%
Kapitalisierung:
|
Volumen (24h):